Eastern Cooperative Oncology Group Performance Status
The ECOG Performance Status Scale is a widely used tool that helps doctors measure how cancer affects a patient’s ability to perform daily activities and care for themselves, playing a crucial role in treatment decisions and predicting outcomes.
Table of contents
- What is Performance Status
- The ECOG Performance Status Scale
- Development and Widespread Use
- Importance in Cancer Care
- Comparison with Karnofsky Performance Status
What is Performance Status
Performance status is an assessment of a patient’s level of functioning and their capability for self-care. In cancer treatment, performance status plays a key role in treatment decisions and serves as an independent indicator for predicting outcomes in patients with advanced cancer[3]. To conduct clinical trials for cancer treatment in a consistent manner across many participating hospitals, cancer centers, and clinics, standard criteria are needed to measure how the disease impacts a patient’s daily living abilities[1].
It is crucial to thoroughly assess and accurately document performance status for each patient, as many clinical decisions are mainly based on this measurement[3]. While diagnostic test results influence approximately 70% of healthcare decisions, performance status assessment helps doctors understand not just the disease itself, but how it affects a person’s ability to function in their everyday life.
The ECOG Performance Status Scale
The ECOG Performance Status Scale describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability such as walking and working[1]. The scale uses numbers from 0 to 5, with each number representing a different level of functioning[4].
The scale is organized as follows:
- Grade 0: Fully active, able to carry on all activities from before the disease without restriction
- Grade 1: Restricted in physically strenuous activity but able to walk around and carry out work of a light or sedentary nature, such as light housework or office work
- Grade 2: Able to walk around and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours
- Grade 3: Capable of only limited self-care; confined to bed or chair more than 50% of waking hours
- Grade 4: Completely disabled; cannot carry on any self-care; totally confined to bed or chair
- Grade 5: Dead[1]
Development and Widespread Use
The ECOG Performance Status Scale was developed by the Eastern Cooperative Oncology Group, now known as the ECOG-ACRIN Cancer Research Group. Key elements of the ECOG scale first appeared in medical literature in 1960, and the scale was formally published in 1982[1]. The scale circulates in the public domain and is therefore available for public use.
Researchers worldwide consider the ECOG Performance Status Scale when planning cancer clinical trials to study new treatments. This numbering scale is one way to define the population of patients to study in a trial and guide physicians who enroll patients into those studies[1]. The scale is used by oncology healthcare professionals around the world to assess performance status of cancer patients before making decisions on systemic anticancer therapy[3].
Importance in Cancer Care
The ECOG Performance Status Scale is used by doctors and researchers to assess how a patient’s disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and outlook[4]. It is also a way for physicians to track changes in a patient’s level of functioning as a result of treatment during a trial[1].
Performance status serves as an independent prognostic indicator for patients with advanced malignancy (cancer). Although it plays an important role in treatment decision and prognosis for oncology patients, medical literature does not have clear consensus on how consistently different healthcare professionals assess performance status[3]. However, studies have shown that there are no significant variations in performance status assessment by different oncology healthcare professionals when using the ECOG tool.
Comparison with Karnofsky Performance Status
The ECOG Performance Status Scale and the Karnofsky Performance Status Scale are two widely used methods to assess the functional status of a patient. Both scales are in the public domain and are used to classify a patient according to their functional impairment, compare the effectiveness of therapies, and assess the prognosis of a patient[1].
The Karnofsky index uses a scale between 100 and 0 and was introduced in a textbook in 1949, making it older than the ECOG scale. There are several ways to compare the two scales, and healthcare professionals may use mapping tables to translate between them[1]. Both ECOG and Karnofsky performance status scores are commonly used by oncology healthcare professionals around the world[3].
